메뉴 건너뛰기




Volumn 73, Issue 6, 1996, Pages 259-263

Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor

Author keywords

ALL; GM CSF; Intensive chemotherapy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

EID: 0030469229     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050238     Document Type: Article
Times cited : (11)

References (22)
  • 3
    • 0024044732 scopus 로고
    • Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease
    • Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ (1988) Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci U S A 85:4869-4873
    • (1988) Proc Natl Acad Sci U S A , vol.85 , pp. 4869-4873
    • Crescenzi, M.1    Seto, M.2    Herzig, G.P.3    Weiss, P.D.4    Griffith, R.C.5    Korsmeyer, S.J.6
  • 4
    • 0023765197 scopus 로고
    • Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Children's Cancer Study Group
    • Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NH, Littman PS, Novak LT, Pyesmany AF. et al (1988) Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Children's Cancer Study Group. Lancet II:921-924
    • (1988) Lancet , vol.2 , pp. 921-924
    • Gaynon, P.S.1    Steinherz, P.G.2    Bleyer, W.A.3    Ablin, A.R.4    Albo, V.C.5    Finklestein, J.Z.6    Grossman, N.H.7    Littman, P.S.8    Novak, L.T.9    Pyesmany, A.F.10
  • 6
    • 0027437548 scopus 로고
    • Granulocyte-colony stimulating factor supportive treatment following invensive chemotherapy consolidation in acute lymphocytic leukaemia in first remission
    • Kantarjian HM, Estey E, O'Brien S, Anaissie E, Beran M, Pierce S, Robertson L, Keating MJ (1993) Granulocyte-colony stimulating factor supportive treatment following invensive chemotherapy consolidation in acute lymphocytic leukaemia in first remission. Cancer 72:2950-2955
    • (1993) Cancer , vol.72 , pp. 2950-2955
    • Kantarjian, H.M.1    Estey, E.2    O'Brien, S.3    Anaissie, E.4    Beran, M.5    Pierce, S.6    Robertson, L.7    Keating, M.J.8
  • 7
    • 0024426103 scopus 로고
    • Clincial use of recombinant human hematopoietic growth factors
    • Laver J, Moore MA (1989) Clincial use of recombinant human hematopoietic growth factors J Natl Cancer Inst 81:1370-1382
    • (1989) J Natl Cancer Inst , vol.81 , pp. 1370-1382
    • Laver, J.1    Moore, M.A.2
  • 11
    • 0029067674 scopus 로고
    • Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukaemia: A randomised phase III trial
    • Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G, et al (1995) Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukaemia: a randomised phase III trial. Blood 86:444-450
    • (1995) Blood , vol.86 , pp. 444-450
    • Ottmann, O.G.1    Hoelzer, D.2    Gracien, E.3    Ganser, A.4    Kelly, K.5    Reutzel, R.6    Lipp, T.7    Busch, F.W.8    Schwonzen, M.9    Heil, G.10
  • 12
    • 0025619479 scopus 로고
    • Hematopoietic growthfactor receptors
    • Park LS, Gillis S, Urdal DL (1990) Hematopoietic growthfactor receptors, Immunol Ser 49:39-75
    • (1990) Immunol Ser , vol.49 , pp. 39-75
    • Park, L.S.1    Gillis, S.2    Urdal, D.L.3
  • 14
    • 12644291645 scopus 로고
    • B-cell acute lymphoblastic leukemia of childhood: Treatment strategy and results in three BFM trials
    • (meeting abstract) Pavia
    • Reiter A, Schrappe M, Henze G, Ludwig WD, Lampert F, Odenwald E, Gadner H, Riehm H (1991) B-cell acute lymphoblastic leukemia of childhood: treatment strategy and results in three BFM trials (meeting abstract). Haematologica (Pavia) 76 [Suppl 4]:105
    • (1991) Haematologica , vol.76 , Issue.4 SUPPL. , pp. 105
    • Reiter, A.1    Schrappe, M.2    Henze, G.3    Ludwig, W.D.4    Lampert, F.5    Odenwald, E.6    Gadner, H.7    Riehm, H.8
  • 15
    • 0018840754 scopus 로고
    • Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukaemia
    • Rivera G, Aur RJ, Dahl GV, Pratt CB, Wood A, Avery TL (1980) Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukaemia. Cancer 45:1284-1288
    • (1980) Cancer , vol.45 , pp. 1284-1288
    • Rivera, G.1    Aur, R.J.2    Dahl, G.V.3    Pratt, C.B.4    Wood, A.5    Avery, T.L.6
  • 20
    • 0022620372 scopus 로고
    • Improved diseasefree survival of children with acute lymphoblastic leukaemia at high risk for early relapse with the New York regimen: A new intensive therapy protocol. A report from the Children's Cancer Study Group
    • Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H et al (1986) Improved diseasefree survival of children with acute lymphoblastic leukaemia at high risk for early relapse with the New York regimen: a new intensive therapy protocol. A report from the Children's Cancer Study Group. J Clin Oncol 4:744-752
    • (1986) J Clin Oncol , vol.4 , pp. 744-752
    • Steinherz, P.G.1    Gaynon, P.2    Miller, D.R.3    Reaman, G.4    Bleyer, A.5    Finklestein, J.6    Evans, R.G.7    Meyers, P.8    Steinherz, L.J.9    Sather, H.10
  • 21
    • 0017695782 scopus 로고
    • Oral non-absorbed antibiotics prevent infection in acute nonlymphoblastic leukaemia
    • Storring RA, Jameson B, McElwain TJ, Wiltshaw E (1977) Oral non-absorbed antibiotics prevent infection in acute nonlymphoblastic leukaemia. Lancet 11:837-840
    • (1977) Lancet , vol.11 , pp. 837-840
    • Storring, R.A.1    Jameson, B.2    McElwain, T.J.3    Wiltshaw, E.4
  • 22
    • 0026717952 scopus 로고
    • Etoposide in combination with intermediate dose cytosine arabinoside (ID ara C) given with the intention of further myelo-ablative therapy for the treatment of refractory or recurrent haematological malignancy
    • Whelan JS, Davis CL, Rohatiner AZ Leahy M, MacCallum PK, Gupta RK, Matthews J, Norton AJ, Amess JA, Lister TA (1992) Etoposide in combination with intermediate dose cytosine arabinoside (ID ara C) given with the intention of further myelo-ablative therapy for the treatment of refractory or recurrent haematological malignancy. Haematol Oncol 10:87-94
    • (1992) Haematol Oncol , vol.10 , pp. 87-94
    • Whelan, J.S.1    Davis, C.L.2    Rohatiner, A.Z.3    Leahy, M.4    MacCallum, P.K.5    Gupta, R.K.6    Matthews, J.7    Norton, A.J.8    Amess, J.A.9    Lister, T.A.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.